| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Accounting Fees | 3,720 | 0 | 0 | 3,720 |
| Name of Bond | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| Colorado Interest Gas Co 6.85% 6/15/37 | 26,855 | 25,244 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| Astrazeneca PLC Spon Adr | 33,455 | 75,960 |
| Celanese Corp New Ser A | 16,994 | 35,988 |
| Coca Cola Co | 20,626 | 47,350 |
| Deutche Bank AG Reg Shs Ord Eur | 60,337 | 9,910 |
| DowDuPont Inc | 22,865 | 83,589 |
| Encana Corp | 15,796 | 2,890 |
| Intel | 7,237 | 23,465 |
| Johnson & Johnson | 25,275 | 64,525 |
| Pfizer | 21,630 | 65,475 |
| Thermo Fisher Scientific | 32,352 | 208,572 |
| United Technologies | 38,303 | 53,240 |
| Verizon Communications Inc | 22,275 | 33,732 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| American Financial Group 6.25% 9/30/54 | AT COST | 25,000 | 25,320 |
| Apollo Investment Corp | AT COST | 30,000 | 29,796 |
| Barclays Bank PLC TA-CYN AIG 6/18/2021 | AT COST | 30,000 | 21,420 |
| Barclays Bank PLC TA-CYN DE 5/14/2021 | AT COST | 30,000 | 28,860 |
| Barclays Bank PLC TA-CYN MS 7/30/2021 | AT COST | 30,000 | 24,240 |
| HSBC USA Inc. TA-CYN BMY 12/02/20 | AT COST | 40,000 | 33,680 |
| Ishares US Pfd Stock ETF Index Fund | AT COST | 50,473 | 42,788 |
| JP Morgan Chase 6.125% | AT COST | 30,000 | 30,420 |
| JP Morgan Chase 6.3% | AT COST | 30,000 | 30,444 |
| JPMorgan Chase Financial TA-CYN DWDP 11/16/20 | AT COST | 25,000 | 20,025 |
| JPMorgan Chase Financial TA-CYN GM 8/6/2021 | AT COST | 25,000 | 22,550 |
| JPMorgan Chase Financial TA-CYN HAL 8/13/2021 | AT COST | 25,000 | 16,925 |
| JPMorgan Chase Financial TA-CYN MDLZ 4/29/20 | AT COST | 30,000 | 28,620 |
| Oaktree Cap Group LLC 6.625% | AT COST | 30,000 | 27,528 |
| Prospect Capital Corp 6.875% | AT COST | 40,000 | 36,976 |
| Stanley Black & Decker Inc | AT COST | 30,000 | 28,452 |
| UBS AG TA-CYN F 10/09/20 | AT COST | 40,000 | 23,720 |
| UBS AG TA-CYN GE 3/06/20 | AT COST | 30,000 | 7,200 |
| UBS AG TA-CYN GE 7/30/20 | AT COST | 40,000 | 11,120 |
| UBS AG TA-CYN HIG 4/16/2021 | AT COST | 30,000 | 26,340 |
| UBS AG TA-CYN KSU 5/21/2021 | AT COST | 25,000 | 22,900 |
| UBS AG TA-CYN PRU 7/23/2021 | AT COST | 25,000 | 21,790 |
| UBS AG TA-CYN UPS 9/24/2021 | AT COST | 40,000 | 32,320 |
| Units INVS Buyback Leaders PRTFO 184 10/20/20 | AT COST | 30,003 | 26,976 |
| Wells Fargo & Co 5.85% | AT COST | 30,000 | 29,484 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Investment Fees | 235 | 235 | 0 | 0 |
| Director Travel | 852 | 0 | 0 | 852 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| Other Investment Income | 22,388 | 22,388 | 0 |
| Option Premiums | 241 | 241 | 0 |
| Description | Amount |
|---|---|
| FMV adjustment on stock and bond contributions | 17,198 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Trustee Fees | 10,050 | 0 | 0 | 10,050 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Foreign Taxes | 48 | 48 | 0 | 0 |
| Federal Taxes | 1,500 | 0 | 0 | 0 |